Latest News for: first-line treatment

Edit

Combination Therapy Approved for Advanced Bladder Cancer Patients in Hong Kong as First-Line Treatment

Hong Kong Standard 30 Jul 2025
A novel combination therapy that integrates an ...
Edit

NMPA Accepts sNDA for Ivonescimab in Combination with Chemotherapy as First-Line Treatment for Advanced Squamous ...

The Daily Times 28 Jul 2025
HONG KONG, July 28, 2025 /PRNewswire/ -- Akeso, Inc.
Edit

NMPA Accepts sNDA for Ivonescimab in Combination with Chemotherapy as First-Line Treatment for Advanced Squamous Non-Small Cell Lung Cancer

PR Newswire 28 Jul 2025
... New Drug Application (sNDA) for ivonescimab (PD-1/VEGF bispecific antibody) in combination with chemotherapy as a first-line treatment for advanced squamous non-small cell lung cancer (sq-NSCLC).
Edit

Opdivo® Intravenous Infusion Approved in Taiwan in Combination with Yervoy® for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Hepatocellular Carcinoma (ONO Pharmaceutical Co Ltd)

Public Technologies 28 Jul 2025
... from the Taiwan Food and Drug Administration (TFDA) in Taiwan, in combination with ipilimumab, for the first-line treatment of adult patients with unresectable or metastatic hepatocellular carcinoma.
Edit

Roche Canada announces Polivy® (polatuzumab vedotin for injection) for the First-Line Treatment of Adults With ...

Canada Newswire 22 Jul 2025
Polivy received the first marketing authorization in Canada on from Health Canada, and on , Québec approved it for public reimbursement for first-line treatment of DLBCL.3,7 This represents a ...
Edit

Akeso Announces First Patient Enrolled in the Phase III Trial（AK112-312/HARMONi-GI6）of Ivonescimab for First-Line Treatment of ...

Bennington Banner 16 Jul 2025
... of ivonescimab in first-line treatment for ....
Edit

Akeso Announces First Patient Enrolled in the Phase III Trial（AK112-312/HARMONi-GI6）of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

PR Newswire 16 Jul 2025
This randomized, controlled, multi-center Phase III clinical trial for first-line treatment of mCRC is one of the company's key initiatives to address the significant unmet clinical need worldwide with ivonescimab.
Edit

Mullein should have been recommended as a first line treatment for sinuses and lungs during ...

Natural News 12 Jul 2025
For centuries, mankind has turned to the earth for remedies — powerful, natural solutions that promote respiratory health without toxic pharmaceutic... .
Edit

Opdivo® Intravenous Infusion Approved in South Korea in Combination with Yervoy® for the First-Line Treatment of Patients with Unresectable or Metastatic Hepatocellular Carcinoma (ONO Pharmaceutical Co Ltd)

Public Technologies 11 Jul 2025
... an anti-PD-1 antibody, on July 10 from the Ministry of Food and Drug Safety (MFDS) in South Korea, for the first-line treatment of patients with unresectable or metastatic hepatocellular carcinoma.
Edit

European Commission Approves TEVIMBRA® in Combination with Chemotherapy as a First-Line Treatment for Nasopharyngeal Carcinoma

The Eagle-Tribune 10 Jul 2025
SAN CARLOS, Calif.--(BUSINESS WIRE)--Jul 10, 2025-- ... .
Edit

European Commission Approves TEVIMBRA� in Combination with Chemotherapy as a First-Line Treatment for Nasopharyngeal Carcinoma

Business Wire 10 Jul 2025
688235), a global oncology company, today announced that the European Commission has approved TEVIMBRA� ...
Edit

Accord Healthcare receives approval for Hetronifly® (Serplulimab), from the Medicines and Healthcare Regulatory Agency (MHRA) for first-line treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

PR Newswire 24 Jun 2025
Serplulimab is the only anti-PD-1 mAb approved for the first-line treatment of ES-SCLC and has now reached over 110,000 patients ... mAb) for the first-line treatment of ES-SCLC is well under way.
Edit

TuHURA Biosciences Initiates Its Phase 3 Accelerated Approval Trial of IFx-2.0 as an Adjunctive Therapy to Keytruda® (pembrolizumab) in First Line Treatment for Advanced or Metastatic Merkel Cell Carcinoma

PR Newswire 24 Jun 2025
... with advanced or metastatic MCC who may not respond to first line treatment with Keytruda® (pembrolizumab)," stated James Bianco, M.D., President and Chief Executive Officer of TuHURA Biosciences.
Edit

Fecal Transplant Potential First-Line Treatment For C. Difficile Infection

Princeton Daily Clarion 20 Jun 2025
Key Takeaways ... .
Edit

Kelun-Biotech's Novel CLDN18.2 ADC SKB315 IND in Combination with Tagolizumab Receives NMPA Approval for the First-Line Treatment of Gastric/Gastro-oesophageal Junction Cancer

PR Newswire 12 Jun 2025
... with immunotherapy for the first-line treatment of CLDN-positive GC/GEJC. Tagitanlimab is the first PD-L1 mAb to receive authorization for the first-line treatment of nasopharyngeal carcinoma (NPC).

Article Search

tools
×
×
×
×